Pacific Biosciences of California Inc
F:P09
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacific Biosciences of California Inc
F:P09
|
US |
|
C
|
China Eastern Airlines Corp Ltd
F:CIAH
|
CN |
|
C
|
Clinuvel Pharmaceuticals Ltd
XMUN:UR9
|
AU |
|
M
|
MFEC PCL
SET:MFEC
|
TH |
Intrinsic Value
Is P09 undervalued or overvalued?
See the intrinsic value estimate for 
Pacific Biosciences of California Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
P09 looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with P09’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Pacific Biosciences of California Does
Pacific Biosciences of California, or PacBio, makes DNA sequencing systems that let researchers read long stretches of genetic code. Its main products are sequencing instruments, the consumable chips and reagents used in those machines, and service and support agreements. The company’s technology is aimed at scientists who need highly detailed views of genomes, not consumer or hospital testing.
- Headquarters
- United States of America US
- Employees
- 485
- IPO date
- Oct 27, 2010
Pacific Biosciences of California has no economic moat
Pacific Biosciences of California Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisLatest Earnings Call
- EPS
- −$0.14
- Expected
- −$0.14
- Surprise
- 0.0%
Revenue & Expenses Breakdown
Pacific Biosciences of California Inc
Earnings Waterfall
Pacific Biosciences of California Inc
The intrinsic value for Pacific Biosciences of California Inc (P09) under the Base Case is hidden EUR.
Compared with the current market price of 22.77 EUR, the stock appears hidden.